CIBINQO was proven to help provide clearer skin and fast itch relief. In studies, some people had clearer skin at 3 months, and some had less itch in just 2 weeks. It’s a once-daily pill that continuously treats eczema, even when you’re not fl aring.
CIBINQO (si-BINK-oh) is a prescription medicine for adults with moderate-to-severe eczema (atopic dermatitis) who didn’t respond to previous treatment and when other treatments, including oral or injected medicines, haven’t worked well or are not right for them.
Get emergency help right away if you develop any symptoms of a heart attack or stroke during treatment with CIBINQO, including:
• discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back
• severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw
• pain or discomfort in your arms, back, neck, jaw, or stomach
• weakness in one part or on one side of your body • slurred speech • shortness of breath with or without chest discomfort • breaking out in a cold sweat • nausea or vomiting • feeling lightheaded
5. Blood clots
Blood clots in the veins of your legs (deep vein thrombosis, DVT) or lungs (pulmonary embolism, PE) can happen in some people taking CIBINQO. This may be life-threatening. Blood clots in the veins of the legs (deep vein thrombosis, DVT) and lungs (pulmonary embolism, PE) have happened more often in people who are 50 years of age and older and with at least 1 heart disease (cardiovascular) risk factor taking a medicine in the class of medicines called Janus kinase (JAK) inhibitors. • Tell your healthcare provider if you have had blood clots in the veins of your legs or lungs in the past.
• Get medical help right away if you have any signs and symptoms of blood clots during treatment with CIBINQO, including: swelling, pain or tenderness in one or both legs; sudden, unexplained chest or upper back pain; or shortness of breath or diffi culty breathing
6. Changes in certain laboratory test results Your healthcare provider should do blood tests before you start taking CIBINQO and during treatment with CIBINQO to check for the following: • low lymphocyte count. Lymphocytes are white blood cells that help the body fi ght off infections.
• low neutrophil count. Neutrophils are white blood cells that help the body fi ght off infections.
• low red blood cell count. This may mean that you have anemia, which may make you feel weak and tired.
© 2022 Pfi zer Inc. All rights reserved. October 2022. PP-CIB-USA-0232 © PARADE Publications 2022. All rights reserved.
• low platelet count. Platelets help form clots and stop or prevent bleeding.
You should not take CIBINQO if your lymphocyte counts, neutrophil counts, red blood cell counts, or platelet counts are too low. Your healthcare provider may stop your CIBINQO treatment for a period of time if needed because of changes in these blood test results. You may also have changes in other laboratory tests, such as your blood cholesterol levels.
Your healthcare provider should do blood tests about 4 weeks after you start taking CIBINQO, and 4 weeks after any increase in your dose of CIBINQO to check your blood cell counts, and as often as needed for your other laboratory tests.
See “What are the possible side eff ects of CIBINQO?” on the next page for more information about the most common side eff ects.
Please see additional IMPORTANT FACTS on the next page. Please see additional IMPOR ANT F CTS on the next page
Visit
CIBINQOPI.com for full Prescribing Information, including BOXED WARNING, and Medication Guide.
Talk to your doctor about CIBINQO
Learn more at
CIBINQO.com An innovation from
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32
